WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997007801) NEW APPLICATIONS OF 5-ETHOXYCARBONYL-2,4,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE OF 2-[N-(1,2-BENZISOTHIAZOLYL-3(2H)ONE-1,1-DIOXIDE]ETHYL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/007801    International Application No.:    PCT/ES1996/000160
Publication Date: 06.03.1997 International Filing Date: 20.08.1996
IPC:
A61K 31/4439 (2006.01), A61K 45/06 (2006.01)
Applicants: LABORATORIOS ALTER, S.A. [ES/ES]; Mateo Inurria, 30, D-28036 Madrid (ES) (For All Designated States Except US).
SUNKEL LETELIER, Carlos [ES/ES]; (ES) (For US Only).
CILLERO CORRAL, Francisco Javier [ES/ES]; (ES) (For US Only).
FAU DE CASA-JUANA MUNOZ, Miguel [ES/ES]; (ES) (For US Only).
ORTEGA NAVARRETE, Pilar [ES/ES]; (ES) (For US Only).
PRIEGO FERNANDEZ DEL CAMPO, Jaime [ES/ES]; (ES) (For US Only).
SANTOS GIL, Luis [ES/ES]; (ES) (For US Only)
Inventors: SUNKEL LETELIER, Carlos; (ES).
CILLERO CORRAL, Francisco Javier; (ES).
FAU DE CASA-JUANA MUNOZ, Miguel; (ES).
ORTEGA NAVARRETE, Pilar; (ES).
PRIEGO FERNANDEZ DEL CAMPO, Jaime; (ES).
SANTOS GIL, Luis; (ES)
Agent: UNGRIA LOPEZ, Javier; Ungria Patentes y Marcas, S.A., Avenida Ramón y Cajal, 78, E-28043 Madrid (ES)
Priority Data:
95500122.7 25.08.1995 EP
Title (EN) NEW APPLICATIONS OF 5-ETHOXYCARBONYL-2,4,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE OF 2-[N-(1,2-BENZISOTHIAZOLYL-3(2H)ONE-1,1-DIOXIDE]ETHYL
(ES) NUEVAS APLICACIONES DEL 5-ETOXICARBONIL-2,4,6-TRIMETIL-1,4-DIHIDROPIRIDINA-3-CARBOXILATO DE 2-[N-(1,2-BENZISOTIAZOLIL-3(2H)ONA-1,1-DIOXIDO]ETILO
(FR) NOUVELLES APPLICATIONS DE 5-ETHOXYCARBONYLE-2,4,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE DE 2-[N-(1,2-BENZISOTHIAZOLYL-3(2H)ONE-1,1-DIOXYDE]ETHYLE
Abstract: front page image
(EN)The invention discloses essentially the application of said product as therapeutical agent for treating patients who suffer from atherosclerosis and/or restenosis and who incur a serious risk of occlusion of the vessels affected by the diseases. Said substance may be administered by mouth or parenteral way, associated or not with other drugs, to patients suffering from atherosclerotic diseases in order to reduce the atheromatous injury and to prevent the restenosis of blood vessels.
(ES)Comprendre principalmente la aplicación de este producto como agente terapéutico de aplicación para el tratamiento de pacientes con aterosclerosis y/o re-estenosis que padecen un riesgo grave de oclulsión de los vasos afectados por la enfermedad. Dicho producto puede administrarse por vía oral o parenteral, asociado o no a otros fármacos, a los pacientes con enfermedad aterosclerótica para reducir la lesión ateromatosa así como para prevenir la re-estenosis de los vasos sanguíneos.
(FR)L'invention consiste essentiellement en l'application de ce produit en tant qu'agent thérapeutique pour le traitement de patients atteints d'athérosclérose et/ou de resténose et qui courent un risque grave d'occlusion de vaisseaux affectés par la maladie. Ce produit peut être administré par voie buccale ou parentérale, associé ou non à d'autres médicaments, à des patients atteints de maladies athérosclérotiques afin de réduire la lésion athéromateuse et prévenir la resténose de vaisseaux sanguins.
Designated States: AU, BR, CA, CN, HU, IL, JP, KP, KR, MX, PL, US.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM).
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)